Janssen Violated FCA, State Laws In HIV Drug Promotions, N.J. Federal Jury Says

(June 18, 2024, 2:16 PM EDT) -- NEWARK, N.J. — A New Jersey federal jury found that Janssen Products LP violated federal and various state false claims laws in its promotion of HIV drugs Prezista and Intelence and ordered it to pay $150 million in damages....

Attached Documents

Related Sections